BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33275265)

  • 21. COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response.
    Gur I; Giladi A; Isenberg YN; Neuberger A; Stern A
    Acta Haematol; 2022; 145(3):297-309. PubMed ID: 35235928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of lymphopenia in children with AIDS.
    Suarez AD; Rao SP; Miller ST
    Clin Pediatr (Phila); 1994 Apr; 33(4):204-8. PubMed ID: 8013166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome.
    Girmenia C; Gentile G; Micozzi A; Petrucci L; Malaspina F; Di Prima A; Baldacci E; Bianchi S; Pugliese P; Turriziani O; Antonelli G; Tombolini V; Foà R; Martelli M
    Acta Haematol; 2020; 143(6):574-582. PubMed ID: 32932252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.
    Ouedraogo E; Gottlieb J; de Masson A; Lepelletier C; Jachiet M; Salle de Chou C; Galicier L; Bagot M; Chevret S; Bouaziz JD
    J Am Acad Dermatol; 2019 Jun; 80(6):1544-1549. PubMed ID: 30981429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of COVID-19-Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated?
    Safarpour D; Srinivasan K; Farooqui M; Roth C; Ghouse M
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):69-72. PubMed ID: 33039356
    [No Abstract]   [Full Text] [Related]  

  • 27. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
    Jin JJ; Butterfield JH; Weiler CR
    J Allergy Clin Immunol Pract; 2015; 3(6):920-5. PubMed ID: 26342744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside.
    Laracy JC; Kamboj M; Vardhana SA
    Curr Opin Infect Dis; 2022 Aug; 35(4):271-279. PubMed ID: 35849516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
    Naimi A; Yashmi I; Jebeleh R; Imani Mofrad M; Azimian Abhar S; Jannesar Y; Heidary M; Pakzad R
    J Clin Lab Anal; 2022 May; 36(5):e24387. PubMed ID: 35385130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
    Berman RS; Feig BW; Hunt KK; Mansfield PF; Pollock RE
    Ann Surg; 2004 Nov; 240(5):852-7. PubMed ID: 15492568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
    Oliva A; Curtolo A; Volpicelli L; Cancelli F; Borrazzo C; Cogliati Dezza F; Marcelli G; Gavaruzzi F; Di Bari S; Ricci P; Turriziani O; Mastroianni CM; Venditti M
    Infection; 2022 Oct; 50(5):1373-1382. PubMed ID: 35781785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Observations of COVID-19 in US Children.
    Agha R; Kojaoghlanian T; Avner JR
    Hosp Pediatr; 2020 Oct; 10(10):902-905. PubMed ID: 32636210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies.
    Shaw JL; Nielson CM; Park JK; Marongiu A; Soff GA
    Eur J Haematol; 2021 May; 106(5):662-672. PubMed ID: 33544940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematological Abnormalities in COVID-19: A Narrative Review.
    Rahman A; Niloofa R; Jayarajah U; De Mel S; Abeysuriya V; Seneviratne SL
    Am J Trop Med Hyg; 2021 Feb; 104(4):1188-1201. PubMed ID: 33606667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.
    Nishikubo CY; Kunkel LA; Figlin R; Belldegrun A; Rosen P; Elashoff R; Wang H; Territo MC
    Cancer; 1996 Dec; 78(11):2421-6. PubMed ID: 8941014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments.
    Martínez JC; Sica RA; Stockerl-Goldstein K; Rubinstein SM
    Acta Haematol; 2022; 145(3):244-256. PubMed ID: 35134811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
    Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
    J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytosis and Lymphopenia Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 17,229 Diseased German Travelers Returning from the Tropics and Subtropics.
    Herbinger KH; Hanus I; Beissner M; Berens-Riha N; Kroidl I; von Sonnenburg F; Löscher T; Hoelscher M; Nothdurft HD; Schunk M
    Am J Trop Med Hyg; 2016 Jun; 94(6):1385-91. PubMed ID: 27068397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.
    Hakki M; Rattray RM; Press RD
    J Clin Virol; 2015 Jul; 68():1-5. PubMed ID: 26071326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017].
    Zhang XC; Fan L; Lu H; Qian SX; Chen LJ; Xu W; Li JY; Qu XY; Zhao XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):389-395. PubMed ID: 37096510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.